Browse studies

Find your next paid study

27,300 recruiting studies available now

A Neural Basis for Cognitive Decline Following Deep Brain Stimulation

This research study aims to identify MRI-based brain biomarkers that predict an individual's response to Deep Brain Stimulation (DBS). In particular, this stud…

Parkinson DiseaseMovement Disorders

Estimated

~$10 – $750

Actual pay is set by the research site.

Medical University of South CarolinaNCT05822388

Observational

Assessing Continuous Glucose Monitor Use in Underserved Primary Care Patients

Continuous glucose monitoring (CGM) has demonstrated improved outcomes in both type 1 and type 2 diabetes populations in comparison to traditional methods; how…

Type 2 Diabetes

Estimated

~$10 – $750

Actual pay is set by the research site.

University of NebraskaNCT05766488

Interrogation of Exosome-mediated Intercellular Signaling in Patients With Pancreatic Cancer

The purpose of this study is to isolate and analyze exosomes, which are tiny carriers of important proteins and nucleic acids that serve as messenger systems i…

Pancreatic CancerBenign Pancreatic Disease

Estimated

~$10 – $750

Actual pay is set by the research site.

Memorial Sloan Kettering Cancer CenterNCT02393703

Phase 1

A Phase 1/2 Dose-Escalation and Randomized, Controlled, Masked Expansion Trial of Intravitreal 4D-150 Gene Therapy in Adults With Neovascular (Wet) Age-Related Macular Degeneration

Phase 1/2 dose-escalation and randomized, controlled, masked expansion trial in adults with wet AMD undergoing active anti-VEGF treatment. Substudies will eva…

Neovascular (Wet) Age-Related Macular Degeneration

Estimated

~$150 – $4,200

Actual pay is set by the research site.

4D Molecular TherapeuticsNCT05197270

Testing of an Educational Tool for Patients With Melanoma and Concomitant Autoimmune Disease Who Are Candidates for Adjuvant Therapy With Immune Checkpoint Inhibitors: Acceptability and Usability With Patients and Providers

This study learn how easily patients can use an educational tool that will be created for patients with melanoma and pre-existing autoimmune diseases who recei…

Ankylosing SpondylitisAutoimmune DiseaseCrohn Disease+10 more

Estimated

~$10 – $750

Actual pay is set by the research site.

M.D. Anderson Cancer CenterNCT04751396

Phase 3

Investigating the Impact of GLP-1 RA Therapy on Osteosarcopenia in Older Female Adults With Diabetes

The goal of this study is to learn how GLP-1 receptor agonist therapy affects muscle and bone health in older females over age 65 with type 2 diabetes. The ma…

Diabetes Mellitus, Type 2

Estimated

~$50 – $1,500

Actual pay is set by the research site.

Emory UniversityNCT07428746

Phase 3

A Randomised, Double-blind, Placebo-controlled, Phase III Study of Adjuvant Saruparib (AZD5305) in Patients With BRCAm Localised High-Risk Prostate Cancer Receiving Radiotherapy With Androgen Deprivation Therapy (EvoPAR-Prostate02).

The purpose of the study is to demonstrate superiority of Saruparib (AZD5305) relative to placebo added to a standard radiation therapy (RT) + androgen depriva…

Prostate Cancer

Estimated

~$50 – $2,250

Actual pay is set by the research site.

AstraZenecaNCT06952803

Observational

Handheld Point of Care Electro-Diagnostic Device

There are currently several products offering POC EEG, intended to be deployed on each patient individually and continuously. The investigators propose studyin…

Neurologic Findings

Estimated

~$10 – $750

Actual pay is set by the research site.

Indiana UniversityNCT07223827

Phase 2

A Phase 2b / 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Combined Dose-Finding and Cardiovascular Outcome Study to Investigate the Efficacy and Safety of CSL300 (Clazakizumab) in Subjects With End Stage Kidney Disease Undergoing Dialysis

This is a two-part, phase 2b and phase 3 combined prospective, interventional, multicenter, randomized, double-blind, placebo-controlled study. Part 1: Phase …

End Stage Kidney Disease

Estimated

~$75 – $3,000

Actual pay is set by the research site.

CSL BehringNCT05485961

Observational

Assessment of Adolescent and Young Adult Vaccine Confidence and Missed Opportunities for Vaccination in the Mountain West (VACCINE CONFIDENCE - WEST): A Randomized Tailored Vaccine Messaging Intervention

his study will evaluate whether tailored vaccine messaging improves vaccination-related outcomes among parents and caregivers of adolescents. Participants will…

Vaccine ConfidenceAdolescent VaccinationVaccine Uptake

Estimated

~$10 – $750

Actual pay is set by the research site.

University of UtahNCT07878442

Phase 1

A Phase 1 Study of the Antibody-Radionuclide Conjugate SLR-108 for Positron Emission Tomography Imaging in Subjects With Metastatic Solid Tumors

This is a Phase 1 study evaluating the feasibility of using SLR-108 for positron-emission tomography (PET) imaging of metastatic solid tumors.

Metastatic Solid Tumors

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Solve TherapeuticsNCT07728942

Phase 4

A Multicentre, Open-label, Randomised Phase IV Study to Investigate Acalabrutinib Monotherapy Compared to Investigator's Choice of Treatment in Adults (> 18 Years) With Chronic Lymphocytic Leukaemia and Moderate to Severe Cardiac Impairment

This will be a global Phase IV, open-label, randomised study to evaluate the safety and tolerability of acalabrutinib (monotherapy, 100 mg orally \[po\], twice…

Chronic Lymphocytic LeukaemiaModerate to Severe Cardiac Impairment

Estimated

~$25 – $1,500

Actual pay is set by the research site.

AstraZenecaNCT06651970